A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

NCT06797869 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy

Interventions

DRUG: CagriSema (Cagrilintide B and Semaglutide I)
DRUG: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Sponsor

Novo Nordisk A/S